In this article, we will explore the different facets of Fluocortin butyl and its impact on today's society. From its historical origins to its relevance today, we will analyze the different aspects that make Fluocortin butyl a topic of interest to a wide variety of people. Through a multidisciplinary approach, we will examine the economic, social, cultural and political implications of Fluocortin butyl, with the aim of understanding its influence on the contemporary world. Likewise, we will immerse ourselves in the debates and controversies that have arisen around this topic, considering different perspectives and opinions to offer a complete overview of its importance. Join us on this tour of Fluocortin butyl and discover its significance today!
Clinical data | |
---|---|
Trade names | Lenen, Novoderm, Varlane, Vaspit |
Other names | FCB; SHK-203; Fluocortin 21-butylate; Fluocortin butylate; Fluocortolone-21-carboxylate 21-butyl; 6α-Fluoro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-oic acid butyl ester |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.050.476 |
Chemical and physical data | |
Formula | C26H35FO5 |
Molar mass | 446.559 g·mol−1 |
3D model (JSmol) | |
| |
|
Fluocortin butyl (brand names Lenen, Novoderm, Varlane, Vaspit), or fluocortin 21-butylate, is a synthetic glucocorticoid corticosteroid which is marketed in Germany, Belgium, Luxembourg, Spain, and Italy. Chemically, it is the butyl ester derivative of fluocortin.
It was patented in 1971 and approved for medical use in 1977.